HEADER HYDROLASE/HYDROLASE INHIBITOR 24-SEP-03 1R1L TITLE STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REACTIVE TITLE 2 LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-NORLEUCINE-LF) CAVEAT 1R1L NAG L 841 HAS WRONG CHIRALITY AT ATOM C1 NAG I 901 HAS WRONG CAVEAT 2 1R1L CHIRALITY AT ATOM C1 NAG I 942 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 1R1L C1 NAG I 962 HAS WRONG CHIRALITY AT ATOM C1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTITHROMBIN-III; COMPND 3 CHAIN: L, I; COMPND 4 SYNONYM: ATIII, PRO0309; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ANTITHROMBIN P14-P9 PEPTIDE; COMPND 7 CHAIN: C; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: EXOGENOUS TRIPEPTIDE FORMYL-(NLE)LF; COMPND 11 CHAIN: D; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: BLOOD; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN HOMO SAPIENS SOURCE 9 (HUMAN).; SOURCE 10 MOL_ID: 3; SOURCE 11 SYNTHETIC: YES KEYWDS SERPIN, LOOP-SHEET POLYMER, BETA-BARREL, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.ZHOU,J.A.HUNTINGTON,D.A.LOMAS,P.E.STEIN,R.W.CARRELL REVDAT 6 15-NOV-23 1R1L 1 REMARK REVDAT 5 23-AUG-23 1R1L 1 HETSYN REVDAT 4 29-JUL-20 1R1L 1 CAVEAT COMPND REMARK HETNAM REVDAT 4 2 1 LINK SITE REVDAT 3 13-JUL-11 1R1L 1 VERSN REVDAT 2 24-FEB-09 1R1L 1 VERSN REVDAT 1 05-OCT-04 1R1L 0 JRNL AUTH A.ZHOU,J.A.HUNTINGTON,D.A.LOMAS,P.E.STEIN,R.W.CARRELL JRNL TITL SERPINS AND THE DESIGN OF PEPTIDES TO BLOCK INTERMOLECULAR JRNL TITL 2 BETA-LINKAGES JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 31687 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.249 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1602 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3120 REMARK 3 BIN FREE R VALUE : 0.3600 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 264 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.022 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6666 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 113 REMARK 3 SOLVENT ATOMS : 119 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 59.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 49.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.27000 REMARK 3 B22 (A**2) : 6.81000 REMARK 3 B33 (A**2) : -7.08000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -7.45000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32 REMARK 3 ESD FROM SIGMAA (A) : 0.44 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.50 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.800 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: MAXIMUM LIKELIHOOD TARGET REMARK 4 REMARK 4 1R1L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-OCT-03. REMARK 100 THE DEPOSITION ID IS D_1000020326. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-DEC-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.8 REMARK 200 NUMBER OF CRYSTALS USED : 3 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SRS REMARK 200 BEAMLINE : PX14.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.978 REMARK 200 MONOCHROMATOR : COOLED LIQUID GALLIUM REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, TRUNCATE REMARK 200 DATA SCALING SOFTWARE : CCP4 (TRUNCATE) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31707 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 25.080 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 3.100 REMARK 200 R MERGE (I) : 0.16300 REMARK 200 R SYM (I) : 0.13500 REMARK 200 FOR THE DATA SET : 4.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.87 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.05300 REMARK 200 R SYM FOR SHELL (I) : 0.43800 REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1LK6 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, SODIUM CACODYLATE, AMMONIUM REMARK 280 FLUORIDE, GLYCEROL, PH 6.8, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 50.21050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: L, I, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS L 1 REMARK 465 GLY L 2 REMARK 465 SER L 3 REMARK 465 PRO L 4 REMARK 465 ARG L 24 REMARK 465 SER L 25 REMARK 465 PRO L 26 REMARK 465 GLU L 27 REMARK 465 LYS L 28 REMARK 465 LYS L 29 REMARK 465 ALA L 30 REMARK 465 THR L 31 REMARK 465 GLU L 32 REMARK 465 ASP L 33 REMARK 465 GLU L 34 REMARK 465 GLY L 35 REMARK 465 SER L 36 REMARK 465 GLU L 37 REMARK 465 GLN L 38 REMARK 465 LYS L 39 REMARK 465 ILE L 40 REMARK 465 PRO L 41 REMARK 465 LYS L 432 REMARK 465 HIS I 1 REMARK 465 GLY I 2 REMARK 465 SER I 3 REMARK 465 PRO I 4 REMARK 465 ALA I 30 REMARK 465 THR I 31 REMARK 465 GLU I 32 REMARK 465 ASP I 33 REMARK 465 GLU I 34 REMARK 465 GLY I 35 REMARK 465 SER I 36 REMARK 465 GLU I 37 REMARK 465 GLN I 38 REMARK 465 LYS I 39 REMARK 465 ILE I 40 REMARK 465 LYS I 432 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O LEU I 417 OD1 ASN I 418 1.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA L 10 164.41 -48.74 REMARK 500 ASP L 72 -11.93 -45.51 REMARK 500 ASN L 96 -132.44 64.89 REMARK 500 LYS L 107 19.16 58.52 REMARK 500 SER L 112 88.88 -55.25 REMARK 500 GLU L 113 -148.47 -145.72 REMARK 500 LYS L 114 -42.21 -154.62 REMARK 500 ASP L 200 45.38 -146.78 REMARK 500 LYS L 222 106.08 -164.48 REMARK 500 ALA L 242 -83.33 -31.69 REMARK 500 GLU L 245 -157.18 -101.78 REMARK 500 ARG L 261 122.83 179.95 REMARK 500 VAL L 263 -154.80 -121.99 REMARK 500 ASP L 277 -5.64 74.02 REMARK 500 GLU L 289 -15.19 88.06 REMARK 500 LEU L 343 -32.19 -38.53 REMARK 500 ILE L 354 -67.40 -96.18 REMARK 500 ASP L 360 -12.42 -157.43 REMARK 500 ASP L 361 71.22 -106.76 REMARK 500 ASN L 398 -168.20 -69.68 REMARK 500 ARG L 399 140.56 173.91 REMARK 500 PHE L 402 35.12 -151.19 REMARK 500 LYS L 403 135.23 -25.90 REMARK 500 ALA L 404 -109.67 -114.70 REMARK 500 ARG L 406 69.93 27.02 REMARK 500 ASN I 18 52.68 37.26 REMARK 500 LYS I 28 -162.97 -41.86 REMARK 500 GLU I 42 80.05 101.63 REMARK 500 ALA I 43 5.36 41.73 REMARK 500 ASN I 96 -134.31 55.05 REMARK 500 ILE I 111 75.46 -106.86 REMARK 500 SER I 112 133.85 -20.35 REMARK 500 GLU I 113 16.36 45.99 REMARK 500 TYR I 131 48.56 -102.22 REMARK 500 ALA I 134 177.05 -53.60 REMARK 500 ASN I 135 57.43 -67.70 REMARK 500 ASP I 174 78.70 -105.24 REMARK 500 ASN I 178 75.41 -116.31 REMARK 500 ALA I 206 172.46 -57.16 REMARK 500 ILE I 207 103.78 59.97 REMARK 500 ARG I 261 129.84 -170.67 REMARK 500 VAL I 263 -164.96 -103.45 REMARK 500 ASP I 277 -22.25 69.75 REMARK 500 LEU I 299 82.00 -66.55 REMARK 500 GLU I 357 95.17 61.89 REMARK 500 ARG I 359 53.94 39.59 REMARK 500 ASP I 361 37.77 -91.36 REMARK 500 ASN I 376 -167.52 -161.75 REMARK 500 ALA I 383 -159.42 -67.12 REMARK 500 ASN I 428 98.78 -160.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1LK6 RELATED DB: PDB REMARK 900 2.8A STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P9 REMARK 900 REACTIVE LOOP PEPTIDE AND AN EXOGENOUS TRIPEPTIDE (FORMYL-MLF) REMARK 900 RELATED ID: 1JVQ RELATED DB: PDB REMARK 900 STRUCTURE OF DIMERIC ANTITHROMBIN COMPLEXED WITH A P14-P8 REACTIVE REMARK 900 LOOP PEPTIDE AND AN EXOGENOUS TETRAPEPTIDE DBREF 1R1L L 1 432 UNP P01008 ANT3_HUMAN 33 464 DBREF 1R1L I 1 432 UNP P01008 ANT3_HUMAN 33 464 DBREF 1R1L C 1 7 PDB 1R1L 1R1L 1 7 DBREF 1R1L D 10 12 PDB 1R1L 1R1L 10 12 SEQRES 1 L 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 L 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 L 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 L 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 L 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 L 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 L 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 L 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 L 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 L 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 L 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 L 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 L 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 L 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 L 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 L 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 L 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 L 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 L 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 L 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 L 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 L 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 L 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 L 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 L 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 L 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 L 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 L 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 L 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 L 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 L 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 L 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 L 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 L 432 CYS VAL LYS SEQRES 1 I 432 HIS GLY SER PRO VAL ASP ILE CYS THR ALA LYS PRO ARG SEQRES 2 I 432 ASP ILE PRO MET ASN PRO MET CYS ILE TYR ARG SER PRO SEQRES 3 I 432 GLU LYS LYS ALA THR GLU ASP GLU GLY SER GLU GLN LYS SEQRES 4 I 432 ILE PRO GLU ALA THR ASN ARG ARG VAL TRP GLU LEU SER SEQRES 5 I 432 LYS ALA ASN SER ARG PHE ALA THR THR PHE TYR GLN HIS SEQRES 6 I 432 LEU ALA ASP SER LYS ASN ASP ASN ASP ASN ILE PHE LEU SEQRES 7 I 432 SER PRO LEU SER ILE SER THR ALA PHE ALA MET THR LYS SEQRES 8 I 432 LEU GLY ALA CYS ASN ASP THR LEU GLN GLN LEU MET GLU SEQRES 9 I 432 VAL PHE LYS PHE ASP THR ILE SER GLU LYS THR SER ASP SEQRES 10 I 432 GLN ILE HIS PHE PHE PHE ALA LYS LEU ASN CYS ARG LEU SEQRES 11 I 432 TYR ARG LYS ALA ASN LYS SER SER LYS LEU VAL SER ALA SEQRES 12 I 432 ASN ARG LEU PHE GLY ASP LYS SER LEU THR PHE ASN GLU SEQRES 13 I 432 THR TYR GLN ASP ILE SER GLU LEU VAL TYR GLY ALA LYS SEQRES 14 I 432 LEU GLN PRO LEU ASP PHE LYS GLU ASN ALA GLU GLN SER SEQRES 15 I 432 ARG ALA ALA ILE ASN LYS TRP VAL SER ASN LYS THR GLU SEQRES 16 I 432 GLY ARG ILE THR ASP VAL ILE PRO SER GLU ALA ILE ASN SEQRES 17 I 432 GLU LEU THR VAL LEU VAL LEU VAL ASN THR ILE TYR PHE SEQRES 18 I 432 LYS GLY LEU TRP LYS SER LYS PHE SER PRO GLU ASN THR SEQRES 19 I 432 ARG LYS GLU LEU PHE TYR LYS ALA ASP GLY GLU SER CYS SEQRES 20 I 432 SER ALA SER MET MET TYR GLN GLU GLY LYS PHE ARG TYR SEQRES 21 I 432 ARG ARG VAL ALA GLU GLY THR GLN VAL LEU GLU LEU PRO SEQRES 22 I 432 PHE LYS GLY ASP ASP ILE THR MET VAL LEU ILE LEU PRO SEQRES 23 I 432 LYS PRO GLU LYS SER LEU ALA LYS VAL GLU LYS GLU LEU SEQRES 24 I 432 THR PRO GLU VAL LEU GLN GLU TRP LEU ASP GLU LEU GLU SEQRES 25 I 432 GLU MET MET LEU VAL VAL HIS MET PRO ARG PHE ARG ILE SEQRES 26 I 432 GLU ASP GLY PHE SER LEU LYS GLU GLN LEU GLN ASP MET SEQRES 27 I 432 GLY LEU VAL ASP LEU PHE SER PRO GLU LYS SER LYS LEU SEQRES 28 I 432 PRO GLY ILE VAL ALA GLU GLY ARG ASP ASP LEU TYR VAL SEQRES 29 I 432 SER ASP ALA PHE HIS LYS ALA PHE LEU GLU VAL ASN GLU SEQRES 30 I 432 GLU GLY SER GLU ALA ALA ALA SER THR ALA VAL VAL ILE SEQRES 31 I 432 ALA GLY ARG SER LEU ASN PRO ASN ARG VAL THR PHE LYS SEQRES 32 I 432 ALA ASN ARG PRO PHE LEU VAL PHE ILE ARG GLU VAL PRO SEQRES 33 I 432 LEU ASN THR ILE ILE PHE MET GLY ARG VAL ALA ASN PRO SEQRES 34 I 432 CYS VAL LYS SEQRES 1 C 7 ACE SER GLU ALA ALA ALA SER SEQRES 1 D 3 NLE LEU PHE MODRES 1R1L NLE D 10 LEU NORLEUCINE HET ACE C 1 3 HET NLE D 10 8 HET NAG L 801 15 HET NAG L 841 15 HET NAG I 901 15 HET NAG I 941 15 HET NAG I 942 15 HET NAG I 961 15 HET NAG I 962 15 HET GOL C 200 6 HET FOR D 9 2 HETNAM ACE ACETYL GROUP HETNAM NLE NORLEUCINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM GOL GLYCEROL HETNAM FOR FORMYL GROUP HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 ACE C2 H4 O FORMUL 4 NLE C6 H13 N O2 FORMUL 5 NAG 7(C8 H15 N O6) FORMUL 12 GOL C3 H8 O3 FORMUL 13 FOR C H2 O FORMUL 14 HOH *119(H2 O) HELIX 1 1 LYS L 11 ILE L 15 5 5 HELIX 2 2 ALA L 43 SER L 69 1 27 HELIX 3 3 SER L 79 LEU L 92 1 14 HELIX 4 4 CYS L 95 PHE L 106 1 12 HELIX 5 5 LYS L 107 ILE L 111 5 5 HELIX 6 6 GLN L 118 ARG L 132 1 15 HELIX 7 7 ASN L 155 GLY L 167 1 13 HELIX 8 8 ASN L 178 THR L 194 1 17 HELIX 9 9 PRO L 203 ILE L 207 5 5 HELIX 10 10 SER L 230 THR L 234 5 5 HELIX 11 11 ALA L 264 GLY L 266 5 3 HELIX 12 12 LEU L 292 LYS L 297 1 6 HELIX 13 13 THR L 300 LEU L 311 1 12 HELIX 14 14 LEU L 331 GLY L 339 1 9 HELIX 15 15 VAL L 341 SER L 345 5 5 HELIX 16 16 ASP I 6 ALA I 10 5 5 HELIX 17 17 LYS I 11 ILE I 15 5 5 HELIX 18 18 ASN I 45 SER I 69 1 25 HELIX 19 19 SER I 79 LEU I 92 1 14 HELIX 20 20 CYS I 95 PHE I 106 1 12 HELIX 21 21 LYS I 107 ILE I 111 5 5 HELIX 22 22 ASP I 117 TYR I 131 1 15 HELIX 23 23 ASN I 155 GLY I 167 1 13 HELIX 24 24 ASN I 178 THR I 194 1 17 HELIX 25 25 SER I 230 THR I 234 5 5 HELIX 26 26 ALA I 264 GLY I 266 5 3 HELIX 27 27 SER I 291 LEU I 299 1 9 HELIX 28 28 THR I 300 GLU I 310 1 11 HELIX 29 29 LEU I 331 MET I 338 1 8 HELIX 30 30 VAL I 341 SER I 345 5 5 SHEET 1 A18 ILE L 76 LEU L 78 0 SHEET 2 A18 THR L 419 VAL L 426 -1 O ARG L 425 N ILE L 76 SHEET 3 A18 PHE L 408 GLU L 414 -1 N VAL L 410 O GLY L 424 SHEET 4 A18 ILE L 279 LEU L 285 -1 N ILE L 284 O LEU L 409 SHEET 5 A18 GLN L 268 PRO L 273 -1 N LEU L 272 O MET L 281 SHEET 6 A18 SER L 246 ARG L 262 -1 N ARG L 261 O VAL L 269 SHEET 7 A18 ARG L 235 TYR L 240 -1 N ARG L 235 O MET L 251 SHEET 8 A18 SER L 246 ARG L 262 -1 O MET L 251 N ARG L 235 SHEET 9 A18 GLU L 312 SER L 330 -1 O VAL L 318 N GLN L 254 SHEET 10 A18 THR I 386 ILE I 390 1 O VAL I 389 N HIS L 319 SHEET 11 A18 GLU L 312 SER L 330 1 N HIS L 319 O VAL I 389 SHEET 12 A18 VAL L 364 VAL L 375 -1 O VAL L 375 N PHE L 323 SHEET 13 A18 GLY L 379 ILE L 390 -1 O GLU L 381 N GLU L 374 SHEET 14 A18 LEU L 213 LEU L 224 -1 N PHE L 221 O ALA L 382 SHEET 15 A18 LYS L 139 SER L 142 -1 N VAL L 141 O TYR L 220 SHEET 16 A18 LEU L 213 LEU L 224 -1 O TYR L 220 N VAL L 141 SHEET 17 A18 ARG L 145 ASP L 149 -1 N ARG L 145 O VAL L 216 SHEET 18 A18 LYS L 169 LEU L 173 1 O GLN L 171 N LEU L 146 SHEET 1 B 2 THR L 153 PHE L 154 0 SHEET 2 B 2 VAL L 355 GLU L 357 -1 O GLU L 357 N THR L 153 SHEET 1 C 7 ILE I 76 LEU I 78 0 SHEET 2 C 7 THR I 419 VAL I 426 -1 O ARG I 425 N ILE I 76 SHEET 3 C 7 PHE I 408 GLU I 414 -1 N PHE I 408 O VAL I 426 SHEET 4 C 7 ILE I 279 LEU I 285 -1 N ILE I 284 O LEU I 409 SHEET 5 C 7 GLN I 268 PRO I 273 -1 N LEU I 272 O MET I 281 SHEET 6 C 7 SER I 246 ARG I 262 -1 N ARG I 259 O GLU I 271 SHEET 7 C 7 ARG I 235 TYR I 240 -1 N ARG I 235 O MET I 251 SHEET 1 D 8 ILE I 76 LEU I 78 0 SHEET 2 D 8 THR I 419 VAL I 426 -1 O ARG I 425 N ILE I 76 SHEET 3 D 8 PHE I 408 GLU I 414 -1 N PHE I 408 O VAL I 426 SHEET 4 D 8 ILE I 279 LEU I 285 -1 N ILE I 284 O LEU I 409 SHEET 5 D 8 GLN I 268 PRO I 273 -1 N LEU I 272 O MET I 281 SHEET 6 D 8 SER I 246 ARG I 262 -1 N ARG I 259 O GLU I 271 SHEET 7 D 8 GLU I 312 PRO I 321 -1 O MET I 320 N MET I 252 SHEET 8 D 8 VAL I 400 LYS I 403 1 O PHE I 402 N HIS I 319 SHEET 1 E 6 LYS I 169 LEU I 173 0 SHEET 2 E 6 LYS I 139 ASP I 149 1 N GLY I 148 O LEU I 173 SHEET 3 E 6 LEU I 213 GLY I 223 -1 O TYR I 220 N VAL I 141 SHEET 4 E 6 SER C 2 SER C 7 -1 O ALA C 4 N PHE I 221 SHEET 5 E 6 PHE I 368 VAL I 375 -1 N PHE I 372 O ALA C 5 SHEET 6 E 6 PHE I 323 SER I 330 -1 N ASP I 327 O ALA I 371 SHEET 1 F 4 LYS I 169 LEU I 173 0 SHEET 2 F 4 LYS I 139 ASP I 149 1 N GLY I 148 O LEU I 173 SHEET 3 F 4 LEU I 213 GLY I 223 -1 O TYR I 220 N VAL I 141 SHEET 4 F 4 NLE D 10 LEU D 11 -1 O NLE D 10 N LEU I 215 SSBOND 1 CYS L 8 CYS L 128 1555 1555 2.04 SSBOND 2 CYS L 21 CYS L 95 1555 1555 2.03 SSBOND 3 CYS L 247 CYS L 430 1555 1555 2.02 SSBOND 4 CYS I 8 CYS I 128 1555 1555 2.04 SSBOND 5 CYS I 21 CYS I 95 1555 1555 2.03 SSBOND 6 CYS I 247 CYS I 430 1555 1555 2.03 LINK C ACE C 1 N SER C 2 1555 1555 1.33 LINK C FOR D 9 N NLE D 10 1555 1555 1.33 LINK C NLE D 10 N LEU D 11 1555 1555 1.33 CRYST1 69.171 100.421 87.198 90.00 104.29 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014457 0.000000 0.003682 0.00000 SCALE2 0.000000 0.009958 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011834 0.00000